InflaRx NV (IFRX)
2.235
-0.06
(-2.40%)
USD |
NASDAQ |
Sep 03, 16:00
2.235
0.00 (0.00%)
After-Hours: 20:00
InflaRx Cash and Short Term Investments (Quarterly) : 181.23M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 181.23M |
| March 31, 2026 | 45.86M |
| September 30, 2025 | 52.46M |
| June 30, 2025 | 56.34M |
| March 31, 2025 | 71.14M |
| September 30, 2024 | 64.61M |
| June 30, 2024 | 80.37M |
| March 31, 2024 | 90.63M |
| December 31, 2023 | 99.72M |
| September 30, 2023 | 120.22M |
| June 30, 2023 | 105.95M |
| March 31, 2023 | 70.48M |
| December 31, 2022 | 86.53M |
| September 30, 2022 | 91.71M |
| June 30, 2022 | 96.41M |
| March 31, 2022 | 100.16M |
| December 31, 2021 | 94.86M |
| September 30, 2021 | 108.85M |
| Date | Value |
|---|---|
| June 30, 2021 | 150.84M |
| March 31, 2021 | 161.68M |
| December 31, 2020 | 99.27M |
| September 30, 2020 | 111.87M |
| June 30, 2020 | 110.73M |
| March 31, 2020 | 118.24M |
| December 31, 2019 | 129.63M |
| September 30, 2019 | 148.68M |
| June 30, 2019 | 158.16M |
| March 31, 2019 | 169.38M |
| December 31, 2018 | 178.98M |
| September 30, 2018 | 129.26M |
| June 30, 2018 | 191.58M |
| March 31, 2018 | 141.73M |
| December 31, 2017 | 148.04M |
| September 30, 2017 | 26.11M |
| June 30, 2017 | 28.89M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 16.89B |
| Immatics NV | 449.72M |
| Beam Therapeutics, Inc. | 1.153B |
| Kymera Therapeutics, Inc. | 690.98M |